HTA Core Model for Rapid Relative Effectiveness Assessment (REA) of pharmaceuticals. The consultation will take place between 1 October and 14 November 2012. Unlike the Full EUnetHTA Core Model, the Rapid REA Model doesn’t incorporate economic analyses or detailed examinations of ethical, social, organizational and legal issues. Instead, its focus is on effectiveness and safety issues.
The document and details of how to submit your comments are available here.